A Phase 2 interventional study of Botulinum Toxin Type A Injection (Botulax®) 24Units and Botulinum Toxin Type A Injection (Botulax®) 48Units in Benign Masseteric Hypertrophy, sponsored by Hugel. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2021-11-16.
Sponsored by Hugel · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is A Randomized, Double-blind, Placebo-controlled, Multi-center Phase II Optimal Dose-finding Study to Evaluate the Safety and Efficacy of Botulax® in Subjects with Benign Masseteric Hypertrophy
A Randomized, Double-blind, Placebo-controlled, Multi-center Phase Ⅱ Optimal Dose-finding Study to Evaluate the Safety and Efficacy of Botulax® in Subjects with Benign Masseteric Hypertrophy
Hugel is the lead sponsor of 16 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Botulinum Toxin Type A (Botulax®) 24Units total dose administered intramuscularly to the bilateral masseter muscles.
Drug: Botulinum Toxin Type A Injection (Botulax®) 24Units
Botulinum Toxin Type A (Botulax®) 48Units total dose administered intramuscularly to the bilateral masseter muscles.
Drug: Botulinum Toxin Type A Injection (Botulax®) 48Units
Botulinum Toxin Type A (Botulax®) 72Units total dose administered intramuscularly to the bilateral masseter muscles.
Drug: Botulinum Toxin Type A Injection (Botulax®) 72Units
Botulinum Toxin Type A (Botulax®) 96Units total dose administered intramuscularly to the bilateral masseter muscles.
Drug: Botulinum Toxin Type A Injection (Botulax®) 96Units
Placebo(Normal saline) administered intramuscularly to the bilateral masseter muscles.
Other: Normal Saline
Experimental: Botulax® 24Units
Also known as: Botulax®
Experimental: Botulax® 48Units
Also known as: Botulax®
Experimental: Botulax® 72Units
Also known as: Botulax®
Experimental: Botulax® 96Units
Also known as: Botulax®
Placebo Comparator: Normal Saline
Amount of change from baseline in masseter muscle thickness during maximum clenching
Amount of change from baseline in masseter muscle thickness during maximum clenching by Ultrasonography
Time frame: Baseline to week 12
Amount of change from baseline in masseter muscle thickness during maximum clenching
Amount of change from baseline in masseter muscle thickness during maximum clenching by Ultrasonography
Time frame: Baseline to week 4, 8, 16
Rate of change from baseline in masseter muscle thickness during maximum clenching
Rate of change from baseline in masseter muscle thickness during maximum clenching by Ultrasonography
Time frame: Baseline to week 4, 8, 12, 16
Amount of change from baseline in masseter muscle thickness during resting
Amount of change from baseline in masseter muscle thickness during resting by Ultrasonography
Time frame: Baseline to week 4, 8, 12, 16
Rate of change from baseline in masseter muscle thickness during resting
Rate of change from baseline in masseter muscle thickness during resting by Ultrasonography
Time frame: Baseline to week 4, 8, 12, 16
Amount and rate of change from baseline in lower face volume during maximum clenching
Amount and rate of change from baseline in lower face volume during maximum clenching by 3D imaging
Time frame: Baseline to week 4, 8, 12, 16
Overall improvement of Investigator
Overall improvement of Investigator by assessment scale
Time frame: Baseline to week 4, 8, 12, 16
Overall satisfaction of subject
Subject satisfaction assessment using a scale ranging from Extremely dissatisfied to Extremely satisfied by questionnaire
Time frame: Baseline to week 4, 8, 12, 16
Ran from May 2020 to primary completion in Nov 2020, 5 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Botulinum toxin type A
Hugel